These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 34587580

  • 1. Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011.
    Kim JH, Martins SS, Shmulewitz D, Hasin D.
    Int J Drug Policy; 2022 Jan; 99():103449. PubMed ID: 34587580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
    Bradford AC, Bradford WD, Abraham A, Bagwell Adams G.
    JAMA Intern Med; 2018 May 01; 178(5):667-672. PubMed ID: 29610897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
    Lopez CD, Boddapati V, Jobin CM, Hickernell TR.
    J Am Acad Orthop Surg; 2021 Feb 15; 29(4):e188-e197. PubMed ID: 32404683
    [Abstract] [Full Text] [Related]

  • 8. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E, Gazmararian J.
    J Opioid Manag; 2017 Feb 15; 13(4):229-239. PubMed ID: 28953315
    [Abstract] [Full Text] [Related]

  • 9. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020.
    Castillo-Carniglia A, Rivera-Aguirre A, Santaella-Tenorio J, Fink DS, Crystal S, Ponicki W, Gruenewald P, Martins SS, Keyes KM, Cerdá M.
    Epidemiology; 2023 Jul 01; 34(4):467-475. PubMed ID: 36943813
    [Abstract] [Full Text] [Related]

  • 10. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB, LeBaron VT, Gilson AM.
    Nurs Outlook; 2018 Jul 01; 66(1):56-65. PubMed ID: 28993073
    [Abstract] [Full Text] [Related]

  • 11. Association of Household Opioid Availability With Opioid Overdose.
    Hendricks MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG.
    JAMA Netw Open; 2023 Mar 01; 6(3):e233385. PubMed ID: 36930154
    [Abstract] [Full Text] [Related]

  • 12. Medical and Non-Medical Opioid Use at the Intersection of Gender and Sexual Identity: Associations with State Medical Cannabis Law Status in a U.S. National Sample of Adults.
    Mauro PM, Philbin MM, Greene ER, Askari MS, Martins SS.
    Arch Sex Behav; 2021 Nov 01; 50(8):3551-3561. PubMed ID: 34751862
    [Abstract] [Full Text] [Related]

  • 13. Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States.
    Kaufman DE, Nihal AM, Leppo JD, Staples KM, McCall KL, Piper BJ.
    Pharmacopsychiatry; 2021 Mar 01; 54(2):91-95. PubMed ID: 33621991
    [Abstract] [Full Text] [Related]

  • 14. State prescribing cap laws' association with opioid analgesic prescribing and opioid overdose.
    Tormohlen KN, McCourt AD, Schmid I, Stone EM, Stuart EA, Davis C, Bicket MC, McGinty EE.
    Drug Alcohol Depend; 2022 Nov 01; 240():109626. PubMed ID: 36115221
    [Abstract] [Full Text] [Related]

  • 15. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Treloar C, Dore GJ, Grebely J, ETHOS Engage Study Group.
    Int J Drug Policy; 2021 Oct 01; 96():103421. PubMed ID: 34452808
    [Abstract] [Full Text] [Related]

  • 16. The association between community social vulnerability and prescription opioid availability with individual opioid overdose.
    El Ibrahimi S, Hendricks MA, Little K, Ritter GA, Flores D, Loy B, Wright D, Weiner SG.
    Drug Alcohol Depend; 2023 Nov 01; 252():110991. PubMed ID: 37862877
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.